Deepro nebulizer maker HCmed has announced that Vivo Capital's PANDA Fund has become a strategic investor as of December 27, 2017, saying, "As a healthcare focused investment firm, Vivo will fully support HCmed’s strategic plan to expand in the hand-held nebulizer markets to help relive [sic] global burden of respiratory disease, such as COPD, asthma and cystic … [Read more...] about Nebulizer maker HCmed gets investment from Vivo Capital
Products and Services
Merxin’s MRX003 inhaler gets CE marking
Generic DPI device developer Merxin has announced that its MRX003 capsule based dry powder inhaler has received CE marking certification. The inhaler, which was launched in May 2017, is designed for generic tiotropium products submitted for approval under the 505(j) pathway. Merxin Co-Founder and Director Philippe Rogueda said in a LinkedIn post, "Merxin is … [Read more...] about Merxin’s MRX003 inhaler gets CE marking
Iconovo signs development and licensing agreement with Intas Pharmaceuticals for DPI
Iconovo AB announced that it has signed an agreement with Intas Pharmaceuticals for development and licensing of a DPI for the treatment of asthma and COPD, including the dry powder formulation and a device based on Iconovo's ICOres reservoir inhaler. According to Iconovo, the deal is worth €2.8 million and includes royalties. In June 2017, Iconovo announced the … [Read more...] about Iconovo signs development and licensing agreement with Intas Pharmaceuticals for DPI
Cambustion introduces Aerodynamic Aerosol Classifier for pharmaceutical use
Cambustion presented its Aerodynamic Aerosol Classifier (AAC), a monodisperse aerosol generation system, to a pharmaceutical audience for the first time at DDL 2017, the company said. According to the company, the AAC, which does not require particle charging, can select out aerosols of either solid particles or liquid droplets in a range of 25 nm - 5 μm. … [Read more...] about Cambustion introduces Aerodynamic Aerosol Classifier for pharmaceutical use
Phillips-Medisize to develop connected device for Dance Biopharm’s inhaled insulin
Dance Biopharm announced that it has signed an agreement with Phillips-Medisize for development of a connected version of Dance's Dance 501 insulin soft mist inhaler device. According to the announcement, Phillips-Medisize has already worked on clinical devices for Dance 501, and the new agreement extends their work to potential commercial manufacture. Dance has … [Read more...] about Phillips-Medisize to develop connected device for Dance Biopharm’s inhaled insulin
Propeller Health partners with Express Scripts to provide inhaler monitoring
Propeller Health has partnered with US pharmacy benefits manager Express Scripts to provide Propeller's inhaler monitoring platform to asthma and COPD patients enrolled in Express Scripts' Pulmonary Care Value Program. According to the companies, patients enrolled in a pilot program run by Express Scripts significantly improved adherence and used rescue inhalers 80% … [Read more...] about Propeller Health partners with Express Scripts to provide inhaler monitoring
Pharmaterials acquired by Quotient Sciences
CDMO Pharmaterials, which offers a wide range of development and manufacturing services for inhaled drugs, has been acquired by Quotient Sciences, Quotient said. Pharmaterials was previously owned by PII, which acquired the company in 2008. In 2014, Pharmaterials announced that it was adding a dedicated inhalation development laboratory as part of an expansion of … [Read more...] about Pharmaterials acquired by Quotient Sciences
Copley Scientific launches new breath simulators capable of generating patient-derived breathing profiles
Copley Scientific has announced the availability of 2 new breath simulators, the BRS 2100 and BRS 3100, that can generate patient-derived breathing profiles for inhaler and nebulizer testing in addition to the pharmacopeoeial standard breathing profiles. Compared to previous generations, the new breath simulators are faster an more flexible, the company said. The … [Read more...] about Copley Scientific launches new breath simulators capable of generating patient-derived breathing profiles
Evoke Pharma selects Patheon for manufacture of Gimoti intranasal metoclopramide
Evoke Pharma has announced that has signed a 5-year agreement with CDMO Patheon for commercial manufacturing of Evoke's Gimoti intranasal metoclopramide for the treatment of diabetic gastroparesis. Patheon was acquired by Thermo Fisher earlier this year. In October 2017, Evoke announced that it plans to submit a 505(b)(2) NDA for Gimoti early in 2018 based on … [Read more...] about Evoke Pharma selects Patheon for manufacture of Gimoti intranasal metoclopramide
H&T Presspart opens manufacturing line for dose counter/indicator
In a series of tweets, H&T Presspart has announced the official opening of a new dose counter/dose indicator manufacturing line at its facility in Marsberg, Germany. In 2014, 3M Drug Delivery Systems announced that it had reached a licensing agreement with Presspart for sales of its Dose by Dose counter and dose indicator. According to H&T Presspart, the … [Read more...] about H&T Presspart opens manufacturing line for dose counter/indicator